✦ LIBER ✦

Phase II trial of the combination of carboplatin and irinotecan in elderly patients with small-cell lung cancer

✍ Scribed by Yasunori Murata; Takashi Hirose; Toshimitsu Yamaoka; Takao Shirai; Kentaro Okuda; Tomohide Sugiyama; Sojiro Kusumoto; Masanao Nakashima; Tohru Ohmori; Mitsuru Adachi

Book ID: 116430705
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 255 KB
Volume: 47
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2011.03.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of irinotecan combined wi

Phase II study of irinotecan combined with carboplatin in previously untreated small-cell lung cancer

✍ Kinoshita, A; Fukuda, M; Soda, H; Nagashima, S; Fukuda, M; Takatani, H; Kuba, M; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 100 KB

Phase II study of carboplatin, irinoteca

Phase II study of carboplatin, irinotecan, and thalidomide combination in patients with extensive stage small-cell lung cancer

✍ Riedel, Richard F.; Crawford, Jeffrey; Dunphy, Frank; Herndon II, James E.; Gars 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Phase II study of irinotecan combined wi

Phase II study of irinotecan combined with carboplatin in previously untreated non-small-cell lung cancer

✍ Minoru Fukuda; Mikio Oka; Hiroshi Soda; Akitoshi Kinoshita; Masaaki Fukuda; Seij 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 197 KB

Phase II trial of carboplatin plus oral

Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer

✍ Matsui, K; Masuda, N; Fukuoka, M; Yana, T; Hirashima, T; Komiya, T; Kobayashi, M 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 760 KB

Phase II study of irinotecan and carbopl

Phase II study of irinotecan and carboplatin in patients with the refractory or relapsed small cell lung cancer

✍ Hirose, Takashi; Horichi, Naoya; Ohmori, Tohru; Ogura, Keiichi; Hosaka, Takamich 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Tolerability of a combination of carbopl

Tolerability of a combination of carboplatin and etoposide phosphate in elderly patients with small cell lung cancer. A multicentric phase II clinical trial

✍ Quoix, E; Breton, J.L; Daniel, C; Jacoulet, P; Debieuvre, D; Paillot, N; Kessler 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 119 KB